Shockwave Medical, Inc. Stock price

Equities

SWAV

US82489T1043

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 01:39:49 2024-03-28 pm EDT 5-day change 1st Jan Change
327.9 USD +1.64% Intraday chart for Shockwave Medical, Inc. +14.66% +71.64%
Sales 2024 * 921M Sales 2025 * 1.13B Capitalization 12.06B
Net income 2024 * 187M Net income 2025 * 241M EV / Sales 2024 * 12.5 x
Net cash position 2024 * 509M Net cash position 2025 * 817M EV / Sales 2025 * 9.93 x
P/E ratio 2024 *
66.8 x
P/E ratio 2025 *
52.6 x
Employees 1,468
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.07%
1 week+12.94%
Current month+23.67%
1 month+22.45%
3 months+68.53%
6 months+61.60%
Current year+69.30%
More quotes
1 week
277.32
Extreme 277.32
329.09
1 month
247.03
Extreme 247.025
329.09
Current year
186.33
Extreme 186.33
329.09
1 year
157.00
Extreme 157
329.09
3 years
98.89
Extreme 98.89
329.09
5 years
22.01
Extreme 22.01
329.09
10 years
22.01
Extreme 22.01
329.09
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 17-04-30
President 49 18-10-31
Director of Finance/CFO 42 Feb. 04
Members of the board TitleAgeSince
Director/Board Member 58 20-07-15
Director/Board Member 51 23-05-15
Director/Board Member 72 11-02-28
More insiders
Date Price Change Volume
24-03-28 327.1 +1.38% 452 015
24-03-27 322.6 +2.07% 1,423,833
24-03-26 316.1 +10.04% 3,331,415
24-03-25 287.2 +2.24% 549,025
24-03-22 280.9 -1.51% 400,862

Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT

More quotes
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
322.6 USD
Average target price
266 USD
Spread / Average Target
-17.55%
Consensus
  1. Stock
  2. Equities
  3. Stock Shockwave Medical, Inc. - Nasdaq